Word

DENDREON TARGETING CANCER, TRANSFORMING LIVES

Status

Registered

Status Code

700

Status Date

Tuesday, July 6, 2021

Serial Number

90243305

Registration Number

6408192

Registration Date

Tuesday, July 6, 2021

Mark Type

3000

Filing Date

Thursday, October 8, 2020

Published for Opposition

Tuesday, April 20, 2021

Trademark Owner History

Dendreon Pharmaceuticals LLC - Original Registrant

Classifications

5 Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases

The mark consists of the term "Dendreon" having a capital "D" and lowercase "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e," "o," and "n," the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n," resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.

Trademark Events

Apr 20, 2023

Teas Change Of Correspondence Received

Apr 20, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Apr 20, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 6, 2021

Registered-Principal Register

Apr 20, 2021

Official Gazette Publication Confirmation E-Mailed

Apr 20, 2021

Published For Opposition

Mar 31, 2021

Notification Of Notice Of Publication E-Mailed

Mar 12, 2021

Approved For Pub - Principal Register

Mar 8, 2021

Assigned To Examiner

Nov 25, 2020

Notice Of Design Search Code E-Mailed

Nov 24, 2020

New Application Office Supplied Data Entered

Oct 12, 2020

New Application Entered